Scientific Sessions 2025  /  Biological and Pragmatic Interventions in Heart Failure: From Present to Future  /  Discussant: ANSWER-HF
Logo

American Heart Association

  53
  0

Final ID:

Discussant: ANSWER-HF

  • Pfeffer, Marc  ( BRIGHAM and WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Solomon, Scott  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Lopes, Renato  ( DUKE CLINICAL RESEARCH , Durham , North Carolina , United States )
    • Author Disclosures:
    Marc Pfeffer: DO have relevant financial relationships ; Consultant:Alexion:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Jazz:Past (completed) ; Consultant:Intellia:Active (exists now) ; Individual Stocks/Stock Options:DalCor:Active (exists now) ; Consultant:DalCor:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) | Scott Solomon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GSK, Ionis, Lilly,NIH/NHLBI, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, US2.AI:Active (exists now) ; Consultant:Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, Askbio, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, GSK, Intellia, Lilly, Novartis, Roche, Theracos, Quantum Genomics, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, Valo, Synhale, Recordati:Active (exists now) | Renato Lopes: DO have relevant financial relationships ; Consultant:Pfizer:Active (exists now) ; Consultant:Medtronic:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Past (completed) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Bayer:Past (completed) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Daiichi Sankyo:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Biological and Pragmatic Interventions in Heart Failure: From Present to Future

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Discussant: BioVAT-HF DZHK20

Wu Joseph, Margulies Kenneth

Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial

Lakdawala Neal, Burroughs Melissa, Claggett Brian, Costabel Juan, Correia Edileide, Dybro Anne, Elliott Perry, Kulac Ian, Lewis Gregory, Mann Amy, Nair Ajith, Garcia-pavia Pablo, Poulsen Steen, Reant Patricia, Schulze Christian, Solomon Scott, Wang Andrew, Sohn Regina, Berhane Indrias, Heitner Stephen, Jacoby Daniel, Kupfer Stuart, Maron Martin, Malik Fady, Wohltman Amy, Fifer Michael, Januzzi James, Masri Ahmad, Merkely Béla, Nassif Michael, Pena Pena Maria Luisa, Barriales-villa Roberto, Bilen Ozlem

More abstracts from these authors:
Optimal Anti-Thrombotic Therapy in Acute MI

Lopes Renato

The Arc of Heart Failure

Pfeffer Marc

You have to be authorized to contact abstract author. Please, Login
Not Available